147 related articles for article (PubMed ID: 6249092)
1. Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors.
Rosenfeld MR; Makman MH; Ahn HS; Thal LJ; Mishra RK; Katzman R
Adv Biochem Psychopharmacol; 1980; 23():83-93. PubMed ID: 6249092
[TBL] [Abstract][Full Text] [Related]
2. The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain.
Rosenfeld MR; Makman MH
J Pharmacol Exp Ther; 1981 Mar; 216(3):526-31. PubMed ID: 7205633
[TBL] [Abstract][Full Text] [Related]
3. Interaction of dopaminergic ergot derivatives with cyclic nucleotide system.
Spano PF; Saiani L; Memo M; Trabucchi M
Adv Biochem Psychopharmacol; 1980; 23():95-102. PubMed ID: 6249093
[No Abstract] [Full Text] [Related]
4. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Enjalbert A; Bockaert J
Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
[TBL] [Abstract][Full Text] [Related]
5. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
[TBL] [Abstract][Full Text] [Related]
6. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
7. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
[TBL] [Abstract][Full Text] [Related]
8. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
Gnegy ME; Bernabei A; Treisman G
J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
[TBL] [Abstract][Full Text] [Related]
10. Striatal dopamine receptors and adenylyl cyclase activity in a rat model of alcohol addiction: effects of ethanol and lisuride treatment.
May T; Wolf U; Wolffgramm J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1195-203. PubMed ID: 8531081
[TBL] [Abstract][Full Text] [Related]
11. Development of functional dependence on ethanol in dopaminergic systems.
Tabakoff B; Hoffman PL
J Pharmacol Exp Ther; 1979 Feb; 208(2):216-22. PubMed ID: 570225
[TBL] [Abstract][Full Text] [Related]
12. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
Sibley DR; Creese I
Mol Pharmacol; 1983 May; 23(3):585-93. PubMed ID: 6223205
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
14. Central monoamine synapses as sites of action for ergot drugs.
Fuxe K; Ogren SO; Agnati LF; Andersson K; Hall H; Köhler C; Fredholm B
Adv Biochem Psychopharmacol; 1980; 23():41-62. PubMed ID: 6104914
[TBL] [Abstract][Full Text] [Related]
15. Activation of adenylate cyclase by ethanol in mouse striatal tissue.
Rabin RA; Molinoff PB
J Pharmacol Exp Ther; 1981 Jan; 216(1):129-34. PubMed ID: 7452500
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids.
Holohean AM; White FJ; Appel JB
Eur J Pharmacol; 1982 Jul; 81(4):595-602. PubMed ID: 7117388
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology and biochemistry of dopamine receptors in the central nervous system and peripheral tissue.
Memo M; Missale C; Carruba MO; Spano PF
J Neural Transm Suppl; 1986; 22():19-32. PubMed ID: 2431109
[TBL] [Abstract][Full Text] [Related]
18. Dopamine-sensitive adenylyl cyclase: a receptor mechanism for dopamine.
Kebabian JW
Adv Biochem Psychopharmacol; 1978; 19():131-54. PubMed ID: 29445
[No Abstract] [Full Text] [Related]
19. alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine.
Zhang W; Klimek V; Farley JT; Zhu MY; Ordway GA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1286-92. PubMed ID: 10336518
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
Adham N; Zgombick JM; Bard J; Branchek TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
